Skip Nav Destination
Close Modal
Update search
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
All
- All
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISBN
- EISBN
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Journal
Article Type
Date
Availability
1-7 of 7
Keywords: VEGF
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Journal Articles
Subject Area:
Oncology
Ludmila K. Martin, Tanios Bekaii-Saab, Derek Serna, Paul Monk, Steven K. Clinton, Michael R. Grever, Eric H. Kraut
Journal:
Onkologie
Onkologie (2013) 36 (11): 657–660.
Published Online: 14 October 2013
...Ludmila K. Martin; Tanios Bekaii-Saab; Derek Serna; Paul Monk; Steven K. Clinton; Michael R. Grever; Eric H. Kraut Background: This phase I study evaluated the safety of SU5416, a potent and selective inhibitor of the vascular endothelial growth factor (VEGF) receptor tyrosine kinase Flk-1...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (2013) 36 (11): 674–676.
Published Online: 14 October 2013
... from any ideas, methods, instructions or products referred to in the content or advertisements. Recall-Phänomen Dermatitis Pazopanib VEGF Hintergrund: Pazopanib ist ein Multi-Target-Tyrosin-kinase-Inhibitor, der kürzlich zur Behandlung des fortgeschrittenen klarzelligen...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (2013) 36 (4): 169–174.
Published Online: 18 March 2013
... for glucose transporter 1 (GLUT1), carbonic anhydrase-IX (CA-IX), vascular endothelial growth factor (VEGF), hexokinase type I (HK-I), hexokinase type II (HK-II), and cytoplasmic and nuclear hypoxia-inducible factor (HIF) 1α. Results: The expression of GLUT1 (p = 0.005), VEGF (p = 0.021), HK-II (p = 0.009...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (2013) 36 (3): 102–107.
Published Online: 25 February 2013
... (VEGF), as well as their correlation with angiogenesis and prognosis in gastric carcinoma. Material and Methods: The expression of Rac1, HIF-1α, VEGF, and CD34 (described in terms of microvessel density, MVD) was determined by immunohistochemical staining of tissues from 60 radically resected gastric...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (2012) 35 (6): 376–378.
Published Online: 21 May 2012
... hemangioendothelioma Kidney tumor Sunitinib VEGF VEGFR Case Report · Kasuistik Onkologie 2012;35:376 378 DOI: 10.1159/000338944 Published online: May 21, 2012 Epithelioid Hemangioendothelioma of the Kidney Treated with Sunitinib Yuri Tolkacha Sergey Petrova Evelyne Lerutb Hendrik Van Poppelc aUrology Clinic...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (2012) 35 (Suppl. 1): 21–27.
Published Online: 20 January 2012
... sarcoma subtypes, and inhibition of the vascular endothelial growth factor (VEGF)/VEGF receptor pathway is of special interest in vascular sarcoma subtypes. MDM2 and p53 seem to be interesting targets for STS, but their role has yet to be defined in further clinical trials. Modification of epigenetic...
Journal Articles
Subject Area:
Oncology
Journal:
Onkologie
Onkologie (2008) 31 (10): 535–540.
Published Online: 23 September 2008
...Yunpeng Huang; Zhixiong Lin; Jianliang Zhuang; Yifeng Chen; Jianhua Lin Background: αV integrins and vascular endothelial growth factor (VEGF) have been shown to play an important role in osteosarcoma metastasis. However, their expression in osteosarcoma after chemotherapy remains unknown. Patients...